A medium-sized breast imaging center (part of a nationally recognized multi-facility group) was mid-inspection in 2026 when the MQSA inspector, a contracted state inspector conducting the review on behalf of the FDA, flagged a deficiency.
One of nearly a dozen interpreting physicians on staff had been transferred to another imaging section of the hospital during the inspection cycle. The transfer was routine. No one anticipated it would create a compliance problem. Because the physician continued to interpret mammograms in the new role (even at reduced volume), the full federal ongoing continuing experience requirement remained in effect. Under MQSA, an interpreting physician who performs any mammography interpretations must maintain 960 reads per 24-month period. Fewer mammograms didn't reduce the obligation. It made meeting it harder.
Their count had fallen approximately 120 interpretations short.
The facility's documentation was otherwise complete. The Mammography Medical Outcome Audit was current: reviewed in detail, signed off by the lead interpreting physician. Disposition listings, technologist and physician ongoing continuing experience records, EQUIP reporting tools, monthly peer-review concordance reports, and breast biopsy pathology summaries: all in order. The gap in this one physician's count had not surfaced during any of it.
The inspector asked the breast imaging technologist directly. The deficiency was real.
The call came in at 11 a.m.
The technologist reached out immediately to her Mammologix client support contact and explained the situation. The inspector had approximately one hour remaining on site. Without documentation of sufficient interpretations for this physician, a citation would be issued. The facility's instinct was right: call Mammologix, consult with client support, and work together to determine whether there was anything that could be done.
Mammologix's Client Partnership Manager escalated within minutes, coordinating with the Operations Manager and a data management team in a STAT response. Working from a population of more than 90,000 mammograms performed during the inspection period, the team identified every procedure interpreted by that specific physician, then applied a critical but often-overlooked provision of published MQSA guidance.
When an interpreting physician reviews a current mammogram and interprets a prior comparison study in the same session, both interpretations count toward the ongoing continuing experience requirement. Each comparison interpretation is a second, separately countable read. That provision is documented in MQSA guidance. It is not widely applied. Properly documented from the facility's existing records, the physician's interpretation count was sufficient to meet the minimum 960 required for the period.
Within 45 minutes, Mammologix had compiled a complete report: every applicable patient record identified, every report of test results documented, interpretation counts broken out by month across the full inspection period.
The inspector received the report before the conclusion of the formal inspection.
The facility passed. No violations. No citations. Open for mammograms Monday morning.
After the inspection, Mammologix took it upon itself to make sure this situation could not repeat itself, for any client. An enhanced quality control check is now built into the client partnership: 90 days before a client's anticipated FDA MQSA inspection date, Mammologix automatically generates an imaging personnel ongoing continuing experience compliance report. The report identifies any shortcomings in interpreting physician or technologist counts while there is still time to act. Corrective action can be mapped out with the facility well in advance, not in the 45 minutes before an inspector leaves the building.
This is one of hundreds of situations where the Mammologix partnership model is designed to perform. Not just managing records, but knowing them well enough to act on them when it counts, and building the processes that make the next emergency unnecessary.